Biomarkers for the clinical management of breast cancer: international perspective.

@article{Patani2013BiomarkersFT,
  title={Biomarkers for the clinical management of breast cancer: international perspective.},
  author={Neill R Patani and Lesley-Ann Martin and Mitch Dowsett},
  journal={International journal of cancer},
  year={2013},
  volume={133 1},
  pages={1-13}
}
The higher incidence of breast cancer in developed countries has been tempered by reductions in mortality, largely attributable to mammographic screening programmes and advances in adjuvant therapy. Optimal systemic management requires consideration of clinical, pathological and biological parameters. Oestrogen receptor alpha (ERα), progesterone receptor (PgR) and human epidermal growth factor receptor 2 (HER2) are established biomarkers evaluated at diagnosis, which identify cardinal subtypes… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 48 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 260 references

v1.2, cancer incidence and mortality worldwide: IARC CancerBase No. 10.Available at: http://globocan.iarc.fr

  • J Ferlay, HR Shin, F Bray
  • GLOBOCAN
  • 2008
Highly Influential
3 Excerpts

1942–8

  • Kronblad A Ryden L et al. Cyclin D1 overexpression is a neg Stendahl M, 90
  • M in i R ev ie w 10 Biomarkers of breast…
  • 2013
1 Excerpt

4287–97

  • Berry DA Broadwater G et al. Comparison of HER2 status b Dressler LG, immunohistochemistry to predict benefit from dose escalation of adjuvan 2005, 23
  • M in i R ev ie w Patani et al. 9 Int. J…
  • 2013

Similar Papers

Loading similar papers…